Annual report pursuant to Section 13 and 15(d)

Schedule of Segments (Tables)

v3.3.1.900
Schedule of Segments (Tables)
12 Months Ended
Dec. 31, 2015
Schedule of Segments (Tables)  
Schedule of Segment Reporting Information, by Segment

The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below.

 

 

 

Cannabis and Medical Marijuana Segment

 

Trash Management

 

Corporate and Eliminations

 

Consolidated

2015

 

 

 

 

 

 

 

 

Net sales

$

98,533

$

2,463,225

$

-

$

2,561,758

Income before taxes

 

(608,833)

 

71,578

 

(224,377)

 

(761,632)

Interest income

 

9,318

 

-

 

65,732

 

75,050

Interest expense

 

-

 

18,910

 

(3,278)

 

15,632

Total assets

 

1,673,616

 

1,131,481

 

1,469,964

 

4,275,061

Property additions

 

2,026

 

9,959

 

6,036

 

18,021

Depreciation and amortization

 

1,568

 

30,004

 

3,783

 

35,355

 

 

 

 

 

 

 

 

 

2014

 

 

 

 

 

 

 

 

Net sales

 

5,390

 

2,144,176

 

-

 

2,149,566

Income before taxes

 

(69,332)

 

76,067

 

(471,861)

 

(465,126)

Interest income

 

4,942

 

-

 

30,706

 

35,648

Interest expense

 

-

 

21,387

 

(551)

 

20,836

Total assets

 

1,626,566

 

1,106,498

 

1,261,326

 

3,994,390

Property additions

 

44,978

 

25,007

 

7,103

 

77,088

Depreciation and amortization

 

3,126

 

29,948

 

2,450

 

35,524